We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
6 hedge funds and large institutions have $152K invested in Windtree Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,082% more capital invested
Capital invested by funds: $12.8K → $152K (+$139K)
200% more funds holding
Funds holding: 2 → 6 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
6
Holders Change
+4
Holders Change %
+200%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$95.4K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$71.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$48.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$38.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$14.2K |
Top Sellers
| 1 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$5 |